143 related articles for article (PubMed ID: 36684007)
1. Editorial: Old and new psychoactive substances: Pharmacology and potential applications.
Mayer FP; Luethi D; Areal LB; Sitte HH
Front Psychiatry; 2022; 13():1087005. PubMed ID: 36684007
[No Abstract] [Full Text] [Related]
2. Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.
Varker T; Watson L; Gibson K; Forbes D; O'Donnell ML
J Psychoactive Drugs; 2021; 53(1):85-95. PubMed ID: 32931403
[TBL] [Abstract][Full Text] [Related]
3. Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.
Elsouri KN; Kalhori S; Colunge D; Grabarczyk G; Hanna G; Carrasco C; Aleman Espino A; Francisco A; Borosky B; Bekheit B; Ighanifard M; Astudillo AA; Demory Beckler M
Cureus; 2022 May; 14(5):e25235. PubMed ID: 35747039
[TBL] [Abstract][Full Text] [Related]
4. [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].
Majić T; Jungaberle H; Schmidt TT; Zeuch A; Hermle L; Gallinat J
Fortschr Neurol Psychiatr; 2017 Jul; 85(7):383-392. PubMed ID: 28768346
[No Abstract] [Full Text] [Related]
5. Prevalence of new psychoactive substances (NPS) in Brazil based on oral fluid analysis of samples collected at electronic music festivals and parties.
da Cunha KF; Oliveira KD; Cardoso MS; Arantes ACF; Coser PHP; Lima LN; Maluf ACS; Comis MAC; Huestis MA; Costa JL
Drug Alcohol Depend; 2021 Oct; 227():108962. PubMed ID: 34461412
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.
Simmler LD; Liechti ME
Handb Exp Pharmacol; 2018; 252():143-164. PubMed ID: 29633178
[TBL] [Abstract][Full Text] [Related]
7. 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.
López-Arnau R; Camarasa J; Carbó ML; Nadal-Gratacós N; Puigseslloses P; Espinosa-Velasco M; Urquizu E; Escubedo E; Pubill D
Front Psychiatry; 2022; 13():990405. PubMed ID: 36262632
[TBL] [Abstract][Full Text] [Related]
8. The Illicit Supply of New Psychoactive Substances Within and From China: A Descriptive Analysis.
Zhao M
Int J Offender Ther Comp Criminol; 2022 Apr; 66(5):495-516. PubMed ID: 31375046
[TBL] [Abstract][Full Text] [Related]
9. Prevalence study of drugs and new psychoactive substances in hair of ketamine consumers using a methanolic direct extraction prior to high-resolution mass spectrometry.
Matey JM; Montalvo G; García-Ruiz C; Zapata F; López-Fernández A; Martínez MA
Forensic Sci Int; 2021 Dec; 329():111080. PubMed ID: 34768198
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.
Inouye A; Wolfgang A
Cureus; 2022 Jun; 14(6):e26402. PubMed ID: 35915689
[TBL] [Abstract][Full Text] [Related]
11. Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells.
Simmler LD; Liechti ME
Curr Top Behav Neurosci; 2017; 32():49-72. PubMed ID: 27272068
[TBL] [Abstract][Full Text] [Related]
12. New psychoactive substances in Taiwan: The current situation and initiative for rational scheduling.
Yu WJ; Cottler L; Li JH
J Food Drug Anal; 2021 Mar; 29(1):168-181. PubMed ID: 35696229
[TBL] [Abstract][Full Text] [Related]
13. Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.
Palamar JJ; Acosta P; Sherman S; Ompad DC; Cleland CM
Am J Drug Alcohol Abuse; 2016 Nov; 42(6):624-632. PubMed ID: 27315522
[TBL] [Abstract][Full Text] [Related]
14. New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors.
Van Hout MC; Hearne E
Int J Drug Policy; 2017 Feb; 40():102-110. PubMed ID: 28027812
[TBL] [Abstract][Full Text] [Related]
15. New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic.
Lo Faro AF; Berardinelli D; Cassano T; Dendramis G; Montanari E; Montana A; Berretta P; Zaami S; Busardò FP; Huestis MA
Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829550
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of long-term detection trends of new psychoactive substances in pooled urine from city street portable urinals (London, UK).
Archer JRH; Mendes F; Hudson S; Layne K; Dargan PI; Wood DM
Br J Clin Pharmacol; 2020 Mar; 86(3):517-527. PubMed ID: 32050035
[TBL] [Abstract][Full Text] [Related]
17. Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies.
Costa G; De Luca MA; Piras G; Marongiu J; Fattore L; Simola N
Neural Regen Res; 2020 May; 15(5):802-816. PubMed ID: 31719240
[TBL] [Abstract][Full Text] [Related]
18. Effect of the UK Psychoactive Substances Act 2016 on episodes of toxicity related to new psychoactive substances as reported to the National Poisons Information Service. A time series analysis.
Al-Banaa I; Hawkins L; Hill SL; Lupton DJ; Jackson G; Sandilands EA; Bradberry SM; Thompson JP; Rushton S; Thomas SHL
Int J Drug Policy; 2020 Mar; 77():102672. PubMed ID: 32032867
[TBL] [Abstract][Full Text] [Related]
19. Analytically confirmed presence of psychoactive substances, especially new psychoactive substances in a group of patients hospitalized with mental and behavioural disorders due to the use of psychoactive substances diagnosis.
Engelgardt P; Krzyżanowski M; Piotrowski P; Borkowska-Sztachańska M; Wasilewska A
Int J Occup Med Environ Health; 2022 Aug; 35(4):485-495. PubMed ID: 35543545
[TBL] [Abstract][Full Text] [Related]
20. The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.
Zaretsky TG; Jagodnik KM; Barsic R; Antonio JH; Bonanno PA; MacLeod C; Pierce C; Carney H; Morrison MT; Saylor C; Danias G; Lepow L; Yehuda R
Curr Neuropharmacol; 2024; 22(4):636-735. PubMed ID: 38284341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
